Patient disposition (initial six months)
| Discontinuations | ||||||
|---|---|---|---|---|---|---|
| n | Completed | Adverse event | Death | Lack of efficacy/ disease progression | Other† | |
| *Myocardial infarction. | ||||||
| †Withdrew consent, non-compliance, no longer eligible, lost to follow up. | ||||||
| ISIS 2302 | ||||||
| 2 Week | 99 | 59 | 5 | 1* | 20 | 14 |
| 4 Week | 99 | 58 | 3 | 0 | 32 | 6 |
| All ISIS 2302 | 198 | 117 | 8 | 1* | 52 | 20 |
| Placebo | 101 | 53 | 2 | 0 | 35 | 11 |